Stay updated with breaking news from Staar Surgical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of STAAR Surgical (NASDAQ:STAA – Get Free Report) have been given an average recommendation of “Hold” by the ten ratings firms that are covering the firm, Marketbeat reports. Six analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average twelve-month price objective among […]
STAAR Surgical (NASDAQ:STAA – Get Free Report) is scheduled to be releasing its earnings data after the market closes on Tuesday, May 7th. Analysts expect STAAR Surgical to post earnings of $0.05 per share for the quarter. STAAR Surgical has set its FY24 guidance at $0.70 EPS.Individual that wish to register for the company’s earnings […]
STAAR Surgical (NASDAQ:STAA) has had a great run on the share market with its stock up by a significant 64% over the...
STAAR Surgical (NASDAQ: STAA) recently received a number of ratings updates from brokerages and research firms: 4/11/2024 – STAAR Surgical had its price target raised by analysts at Mizuho from $45.00 to $53.00. They now have a “buy” rating on the stock. 4/8/2024 – STAAR Surgical had its price target raised by analysts at Canaccord […]
Staar Surgical Co. surprised Wall Street earlier this month by saying its U.S. sales were taking off faster than expected.The Lake Forest-based maker of implantable lenses for myopia, astigmatism and presbyopia (Nasdaq: STAA) on April 4 reported preliminary first-quarter revenue would top $77 million, when analysts were expecting $72 million.